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Abstract
Aim: To assess the performance of automated disease detection in diabetic retinopathy screening using two field mydriatic
photography.
Methods: Images from 8,271 sequential patient screening episodes from a South London diabetic retinopathy screening
service were processed by the Medalytix iGrading
TM automated grading system. For each screening episode macular-
centred and disc-centred images of both eyes were acquired and independently graded according to the English national
grading scheme. Where discrepancies were found between the automated result and original manual grade, internal and
external arbitration was used to determine the final study grades. Two versions of the software were used: one that
detected microaneurysms alone, and one that detected blot haemorrhages and exudates in addition to microaneurysms.
Results for each version were calculated once using both fields and once using the macula-centred field alone.
Results: Of the 8,271 episodes, 346 (4.2%) were considered unassessable. Referable disease was detected in 587 episodes
(7.1%). The sensitivity of the automated system for detecting unassessable images ranged from 97.4% to 99.1% depending
on configuration. The sensitivity of the automated system for referable episodes ranged from 98.3% to 99.3%. All the
episodes that included proliferative or pre-proliferative retinopathy were detected by the automated system regardless of
configuration (192/192, 95% confidence interval 98.0% to 100%). If implemented as the first step in grading, the automated
system would have reduced the manual grading effort by between 2,183 and 3,147 patient episodes (26.4% to 38.1%).
Conclusion: Automated grading can safely reduce the workload of manual grading using two field, mydriatic photography
in a routine screening service.
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Introduction
Diabetic retinopathy is one of the most common causes of vision
loss in the developed world. Approximately three million people
are thought to have diabetes in England. Since timely treatment is
effective in reducing vision loss[1], everyone known to have
diabetes and aged over twelve is invited for annual retinal
screening using digital photography.
Screening generates a large amount of image data requiring
grading. As the prevalence of diabetes continues to rise, there is a
concomitant increase in the grading burden[2]. Furthermore, as in
other screening programmes, the majority of images are normal.
Automated grading has been proposed as a method to remove
normal images from the manual grading queue, so reducing the
overall manual workload.
A fully automated system using macular-centred images has been
tested on a number of datasets, one of which included 33,535
consecutive patient episodes[3–5]. These studies were based on a one-
field, staged mydriasis photographic protocol, hence confirmation was
required that the results were applicable to other photographic
protocols, such as two-field, mydriatic photography.
We report here the results of a study testing automated disease
detection including quality assessment using images acquired and
graded using two-field, mydriatic photography.
Methods
Data collection
Images from 8,500 consecutive patient episodes (approximately
6 months of screening data) were extracted from the Wandsworth,
Richmond and Twickenham diabetic retinopathy screening
service (DRSS), South London in 2009. Duplicate visits, non-
screening follow-up visits and test images were excluded, leaving
8,271 unique patient episodes and 36,236 retinal photographs.
The retinal photographs were nominally 45 degree fields of view
acquired using a non-mydriatic fundus camera: 68% were from
Topcon NW6 fundus cameras with Nikon D80 digital single lens
reflex camera (DSLR) backs, while the remainder were acquired
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D30, 30D or 40D DSLR back. The resulting colour images
were between 3.1 and 10.1 megapixels and were stored using
high quality JPEG compression. All patients underwent routine
mydriasis with Tropicamide 1% and, where present, both eyes
were imaged. Two fields were taken per eye: a macula-centred and
a disc-centred view. Where appropriate, more than one image of
each field was taken at the discretion of the retinal screener.
Manual Image grading
Images from all the patient episodes were routinely graded by
the local DRSS, independently of this study, following the
standard grading Pathway 2 (‘‘full disease grading’’) of the English
National Screening Programme for diabetic retinopathy[6].
Where the photographic quality was deemed adequate, the eye
was graded for both retinopathy and maculopathy, as per Table 1.
The grade for each eye was a combined assessment of the macular
and disc fields. Where multiple images were taken of a field, these
were all included in the assessment; the grade for the eye was taken
as the worst grade of all the fields acquired for the eye. The grade
for the patient episode was taken from the eye with the more
serious disease. Disagreements between the DRSS grade and the
automated result were sent for internal arbitration. Disagreements
pertaining to an episode originally graded as referable by the
DRSS were also sent for external arbitration.
Automated image analysis
Automated grading software was purchased for this project
(Medalytix iGrading
TM system, 7 Water Street, Liverpool, L2 0RD)
and run on a HP Proliant DL380 server at St George’s Hospital.
The software is designed to remove normal images from the
manual grading queue. It does this by first checking the image for
adequate clarity and field of view[3] before looking for the early
signs of retinopathy. It may be operated in two modes: the first
looks only for microaneurysms (MA)[3], while the second (MA/
BH/EX) also looks for blots and exudates in addition to
microaneurysms[4]. The software was evaluated here using both
fields from each eye, and also using only the macula-centred field
from each eye. Hence there were four automated strategies tested:
MAs only on macular field alone, MA/BH/EX on macular field
alone, MAs on the macular and disc fields, and MA/BH/EX on
the macular and disc fields. As for manual grading, where more
than one image of a field was acquired these were all included in
the automated analysis: if any of the images were positive then that
eye was treated as positive.
Internal arbitration of disease/no-disease discrepancies
Images where there was a discrepancy between the manual and
automated systems regarding whether disease was present were
internally arbitrated by one of two ‘‘arbitration level’’ graders
within the screening programme (SN and AC). Occasionally
images were re-graded jointly. The arbitration outcomes were
simply disease or no-disease. Since full grading was not performed
the severity of any disease missed by the original DRSS grading
could not be categorized.
External arbitration of referable/non-referable
discrepancies
Where there was a discrepancy between the DRSS grade and
an automated strategy regarding whether an episode was referable
these images were re-graded externally. Graders working in
different screening programmes in England were invited to
participate at the British Association of Retinal Screeners annual
meeting in 2010. The grading took place in February and March
2011, using a web-based grading system based on the features of
the English grading scheme. Graders were able to practise and
become familiar with the system prior to carrying out the
arbitration grading. A similar number of control images, where
the manual and automated system agreed on the presence or
absence of retinopathy, were added so that the graders did not
know whether they were grading a discrepancy. Graders were able
to view all the available images for each eye and each grader was
Table 1. Retinopathy and maculopathy grading scheme for the English National Screening Programme for Diabetic Retinopathy.
Retinopathy (R)
R0 None No visible retinopathy
R1 Background Any microaneurym, haemorrhage or exudates
R2 Pre-proliferative Venous beading, loop or reduplication Intraretinal microvascular abnormality (IRMA)
Multiple deep, round or blot haemorrhages
R3 Proliferative New vessels on the disc (NVD)
New vessels elsewhere (NVE)
Pre-retinal or vitreous haemorrhage
Pre-retinal fibrosis (with or without detachment)
Maculopathy (M)
M0 None No visible maculopathy
M1 Maculopathy Exudate within 1 disc-diameter (DD) of the fovea
Exudate circinate or group within 1DD of fovea
Microaneurysm or haemorrhage within 1DD of fovea if visual acuity is poorer than 6/12.
Image quality
Macular-centred field The macula-centred field is considered adequate if both:
N The centre of the fovea is at least 2DD from the edge of the field of view
N Vessels are visible with 1DD of the centre of the fovea.
Disc-centred field The disc-centred field is considered adequate if both:
N The complete disc is at least 2DD from the edge of the field of view.
N Fine vessels are visible on the disc.
doi:10.1371/journal.pone.0027524.t001
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different English screening programmes took part. Of these 11
were arbitration-level graders, 8 secondary-level graders and 6
primary-level graders.
A consensus criterion, based on the grading of the eleven
arbitration level graders, was used to determine whether each eye
was referable. An eye was considered referable if at least 8/11 of
the arbitration-level graders indicated referable features, and non-
referable when 3/11 or fewer of the arbitration-level graders
indicated a referable feature. When between 4 and 7 graders
indicated a referable feature it was deemed there was insufficient
consensus to assign a grade.
Statistical comparison
The sensitivities of the four automated strategies were compared
for the detection of any retinopathy, referable retinopathy,
unassessable episodes, and for each grade of retinopathy listed in
Table 1. The workload reduction was calculated as the proportion
of images the automated system recorded as both gradeable and
without disease. 95% confidence intervals were calculated on all
measurements.
Information Governance
All the images were abstracted without patient identifiers or
grading information. Manual grading was done prior to image
analysis and without knowledge of the study. Arbitration grading
was done without knowledge of either the software analysis or
prior grading results. Only one person (LW), who was not involved
in any grading or software analysis, had access to both grading
results and image analyses. The study had written consent from
the Chairman of the London Wandsworth Research Ethics
Committee and the Institutional Caldicott Guardian. All partic-
ipants in the English National Screening Programme for Diabetic
Retinopathy agree to the anonymous use of their images for
teaching and research. The study had no effect on the routine
clinical care of patients within the screening programme. Where
there was any question of the effect of grading on patient
management the electronic records were accessed and the
subsequent outcome examined.
Results
Manual grading
Episodes in which the manual and automated systems disagreed
were passed to internal arbitration grading. If the disagreement
involved a referable episode then these were also passed to external
arbitration grading. Of the 8,271 patient episodes included in the
study, four were removed following external arbitration as no
consensus was reached regarding their grade, leaving 8,267
episodes. Of these, 4.2% were considered unassessable by manual
grading. 58.7% were graded as having no retinopathy, 30.0% were
graded as having background retinopathy (R1), 4.8% were graded
as having maculopathy (M1), 1.6% were graded as having pre-
proliferative retinopathy (R2), and 0.7% were graded as having
proliferative retinopathy (R3). Overall, 587 (7.1%) were given
referable grades (i.e. R2, R3 or M1).
Internal arbitration of disease/no disease discrepancies
Of the disease/no-disease discrepancies there were 48 episodes
where the original DRSS grade was disease (R1 or above) but the
arbitration grade was R0 (no disease). These downgraded
discrepancies included eleven referable episodes: one originally
graded R3 (proliferative retinopathy) and 10 graded as M1
(maculopathy). All of these episodes were included in the external
arbitration. There were 326 episodes whose original DRSS grade
was R0 (no disease) but arbitration found disease. Since full
grading was not performed the disease missed by the DRSS
grading could range from background (R1) to proliferative
retinopathy (R3). The significant increase in the number of
images categorised as having disease following internal arbitration
suggests the arbitration process operated at a higher disease
sensitivity than the routine screening service.
External arbitration of referable/non-referable
discrepancies
Referable/non-referable discrepancies from any of the four
automated grading strategies were arbitrated externally. All of
discrepancies concerned maculopathy (R1M1), except for a case
where the original DRSS grade was proliferative retinopathy (R3)
but internal arbitration had downgraded it to no disease (R0).
Combining the discrepancies from the four automated strategies
resulted in 32 eyes for external arbitration. A further 48 eyes, in
which the manual and automated grading agreed, were also
included as control images. The median time for all levels of
grader to complete the 80 eyes was 2.6 hours (interquartile range
2.0 to 3.4 hours).
Figure 1 shows a receiver operator characteristic (ROC) plot for
all the graders who completed the external arbitration. The three
levels of grader (primary, secondary and arbitration) are indicated
separately, since primary level graders may be expected to have a
different sensitivity/specificity trade-off to arbitration level graders.
Nevertheless, even amongst arbitration level graders there is a
range of operating points from high specificity and lower sensitivity
to high sensitivity and lower specificity.
Of the 32 discrepancies presented to the graders, 28/32
achieved a consensus grade; the remaining 4 eyes were excluded
from the analysis. Two of the episodes were considered
unassessable by the arbitrators and nine were graded as non-
referable (including the episode originally DRSS graded as having
proliferative retinopathy which was internally arbitrated as R0).
The remaining 17 eyes were graded as having maculopathy.
However, three of these had only red lesions within the macula
and normal visual acuity and so would have been graded as
background retinopathy (R1) according to the English National
Screening Programme for Diabetic Retinopathy grading scheme.
Hence, of the original 32 discrepancies, 2 unassessable eyes and
14 eyes with maculopathy were missed by the automated system.
Of these, only 6/16 were unanimously graded as unassessable or
referable by the arbitration level graders. Including the grading
from the primary and secondary graders there were only 3/16
images which were unanimously graded as unassessable or
referable by graders of all levels.
Automated grading
Table 2 lists the sensitivities for automated disease detection for
each grade, as well as for any diabetic retinopathy and any referable
diabetic retinopathy. The associated workload reduction of
employing the automated strategy as a disease/no-disease grader
is also shown. The sensitivity for detecting unassessable images
ranged from 97.4% (MA only, macular field) to 99.1% (MA/BH/
EX, both fields). The sensitivity for detecting any retinopathy
ranged from 89.9% (MA/BH/EX, macular field) to 95.8% (MA
only, both fields). The sensitivity for referable retinopathy (i.e. M1,
R2 and R3) ranged from 98.3% (MA/BH/EX, single field) to
99.3% (MA only, both fields). The workload reduction ranged from
26.4% (MA/BH/EX, both fields) to 38.1% (MA only, macular
field). The sensitivities for pre-proliferative and proliferative disease
were 100% using all four automated strategies.
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disease sensitivity using the four automated strategies. The arrows
indicate the 95% confidence intervals on the measurements. While
including the disk centred field detected additional referable cases, it
also resulted in many more non-referable cases being detected,
which would require manual grading. For both the MA only and
MA/BH/EX strategies, including the disk centred field picked up
five additional referable maculopathy cases not detected using the
macular field alone. However, in order to find these five additional
cases an additional 688 non-referable cases were found using MAs
only, or an additional 637 cases using MA/BH/EX. Hence, of the
additional cases found by including the disk centred field, only 5/
688 (0.73% [0.31% to 1.69%]) were referable using MAs only, and
5/637 (0.78% [0.34% to 1.82%]) were referable using MA/BH/
EX.
Discussion
There are three previous published reports of the perfor-
mance of this automated system [3–5] using staged mydriasis and
single-field photography. The present study assessed the perfor-
mance of automated disease detection on an unselected population
of 8,271 subjects from a South London retinal screening service
using mydriatic, two-field photography. The sensitivities for
referable disease using the four automated strategies are very
Figure 1. Receiver operator characteristic (ROC) plot for all the
graders who took part in the external arbitration. The three
levels of grader (primary, secondary and arbitration) are shown by ‘*’, ‘+’
and ‘o’ respectively. All the graders were compared against a consensus
grading calculated from the results from all the arbitration level graders.
Notice even amongst the arbitration level graders there is a range of
operating points from high specificity and lower sensitivity to high
sensitivity and lower specificity.
doi:10.1371/journal.pone.0027524.g001
Table 2. Performance of the four automated strategies for
detecting different grades of disease, together with the
associated workload reduction.
DRSS category
Number identified
by the automated
system
Proportion identified
(%) [95% confidence
interval]
MA/BH/EX (both fields)
Unassessable 343/346 99.1 [97.5 to 99.7]
R0 3094/5141 60.2 [58.8 to 61.5]
R1 2065/2193 94.2 [93.1 to 95.1]
M1 390/395 98.7 [97.1 to 99.5]
R2 131/131 100 [97.2 to 100]
R3 61/61 100 [94.1 to 100]
Any retinopathy 2647/2780 95.2 [94.4 to 95.9]
Referable 582/587 99.1 [98.0 to 99.6]
(Workload reduction 2183/8267 26.4 [25.5 to 27.4])
MA(both fields)
Unassessable 339/346 98.0 [95.9 to 99.0]
R0 2806/5141 54.6 [53.2 to 55.9]
R1 2080/2193 94.8 [93.8 to 95.7]
M1 391/395 99.0 [97.4 to 99.6]
R2 131/131 100.0 [97.2 to 100.0]
R3 61/61 100 [94.1 to 100]
Any retinopathy 2663/2780 95.8 [95.0 to 96.5]
Referable 583/587 99.3 [98.3 to 99.7]
(Workload reduction 2459/8267 29.7 [28.8 to 30.7])
MA/BH/EX (macular field only)
Unassessable 342/346 98.8 [97.1 to 99.5]
R0 2607/5141 50.7 [49.3 to 52.1]
R1 1921/2193 87.6 [86.2 to 88.9]
M1 385/395 97.5 [95.4 to 98.6]
R2 131/131 100.0 [97.2 to 100.0]
R3 61/61 100 [94.1 to 100]
Any retinopathy 2498/2780 89.9 [88.7 to 90.9]
Referable 577/587 98.3 [96.9 to 99.1]
(Workload reduction 2820/8267 34.1 [33.1 to 35.1])
MA(macular field only)
Unassessable 337/346 97.4 [95.1 to 98.6]
R0 2229/5141 43.4 [42.0 to 44.7]
R1 1976/2193 90.1 [88.8 to 91.3]
M1 386/395 97.7 [95.7 to 98.8]
R2 131/131 100 [97.2 to 100]
R3 61/61 100 [94.1 to 100]
Any retinopathy 2554/2780 91.9 [90.8 to 92.8]
Referable 578/5877 98.5 [97.1 to 99.2]
(Workload reduction 3147/8267 38.1 [37.0 to 39.1])
doi:10.1371/journal.pone.0027524.t002
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using a macular centred, mydriatic photographic protocol
(Table 3).
The performance of automated grading should be compared
with that achieved by manual grading of photographic images.
Several studies have demonstrated the limited sensitivity and
Figure 2. Workload reduction versus referable sensitivity for the four automated strategies. The arrows indicate the 95% confidence
intervals on the measurements.
doi:10.1371/journal.pone.0027524.g002
Table 3. Comparison of per patient sensitivities and workload reduction from this study and three Scottish studies using the same
software.
MA (MAs only) MA/BH/EX (MAs + blots + exudates)
Study Unassessable (%) Referable (%) R2/R3 (%)
Workload
reduction (%)
Unassessable
(%) Referable (%) R2/R3 (%)
Workload
reduction (%)
This study
Macula field
only
97.4 [95.1,98.6]
(337/346)
98.5
[97.1,99.2]
(578/587)
100
[98.0,100]
(192/192)
38.1
[37.0,39.1]
(3147/8267)
98.8
[97.1,99.5]
(342/346)
98.3
[96.9,99.1]
(577/587)
100
[98.0,100]
(192/192)
34.1
[33.1,35.1]
(2820/8267)
This study
Both fields
98.0
[95.9,99.0]
(339/346)
99.3
[98.3,99.7]
(583/587)
100
[98.0,100]
(192/192)
29.7
[28.8,30.7]
(2459/8267)
99.1
[97.5,99.7]
(343/346)
99.1
[98.0,99.6]
(582/587)
100
[98.0,100]
(192/192)
26.4
[25.5,27.4]
(2183/8267)
Philip et al.
2007[3]
99.8
[99.0–100]
(552/553)
98.0
[95.3,99.1]
(241/246)
100
[94.6,100]
(67/67)
45.7
[44.5,46.9]
(3070/6722)
Fleming et al.
2010a[4]
98.6
[97.4,99.3]
(634/643)
95.0
[93.5,96.1]
(1076/1133)
97.6
[95.9,98.6]
(488/500)
39.2
[38.1,40.3]
(2971/7586)
98.8
[97.6,99.4]
(635/643)
96.9
[95.7,97.8]
(1098/1133)
98.2
[96.6,99.1]
(491/500)
38.9
[37.8,40.0]
(2951/7586)
Fleming et al.
2010b [5]
99.8
[99.5,99.9]
(1824/1827)
98.1
[97.3,98.7]
(1603/1634)
100
[99.2,100]
(504/504)
38.4
[37.8,38.9]
(12154/31681)
Note that study [4] is the only one that apparently missed proliferative disease. However, subsequent re-grading of the six supposed proliferative cases downgraded all
cases to non-referable (the six images in question are available as supplementary material from the BJO website).
doi:10.1371/journal.pone.0027524.t003
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athy: some referable disease is missed before the eye is even
graded[7–9]. Furthermore, image grading is not a trivial task and
other studies have reported wide disagreement between grad-
ers[10–13]. The ROC plot in figure 1 indicates the range of
performance that may be expected from different levels of grader
within a screening service. Images are often difficult to interpret
owing to subtle and inconclusive disease features, the presence of
distracting artefacts or the borderline position of lesions. Finally,
very occasionally, a grader makes a mistake and misses a clear
feature. In the external arbitration exercise only 16 of the 32 eyes
originally DRSS graded as referable, but graded negative by one
or more of the automated strategies, were graded as referable by a
consensus of the arbitration level graders. Of these only six were
unanimously graded as referable, meaning that at least one
arbitration level grader would also have missed each of the
remaining 10 cases.
Clinical follow-up information was available for 11/14 episodes
that were graded as normal by the automated system but as
referable maculopathy by external arbitration. Of these, all but
three went for optical coherence tomography (OCT). One of the
patients had laser treatment 10 months after screening. Other
studies have shown that maculopathy and macular oedema
progresses slowly [14,15].
There was a significant difference in workload reduction
depending on whether the macular field alone or both fields were
used (Figure 1). Automated grading using microaneurysms alone
achieved a workload reduction of 38.1% (CI 37.0% – 39.1%) with
the macular field alone and 29.7% (CI 28.8% – 30.7%) with both
fields. The addition of the disc-centred field may be expected to
increase sensitivity, since the manual and automated systems both
have a second opportunity to spot retinopathy. However, it is also
an additional opportunity to detect false positive disease which
decreases the workload reduction. In this study less than 0.8% of the
additional cases generated by including the disk centred field were
referable. No advantage was found using MA/BH/EX over MAs
alone. MA/BH/EX resulted in similar sensitivity but at a higher
false positive rate that decreased the associated workload reduction.
No attempt has been made to estimate the cost-benefits
associated with the workload reduction, as this will depend on
the staffing numbers, salary grades and work throughput in
individual screening services. However, it may be expected that a
38% workload reduction applied to a screening programme would
have considerable benefits, especially given the increasing
prevalence of diabetes.
In conclusion, an automated disease/no-disease grading system
has been tested against data from a retinal screening service using
a mydriatic two-field, photographic protocol. Automated grading
can safely reduce the burden of manual grading with potential
cost-benefits.
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